文献速递外周动脉疾病

肌酸补充对症状性外周动脉疾病患者肾功能影响的随机双盲安慰剂对照试验

Does Creatine Supplementation Affect Renal Function in Patients with Peripheral Artery Disease? A Randomized, Double Blind, Placebo-controlled, Clinical Trial.
PubMed 文献 · Ann Vasc Surg · 2019-09-26

结果显示两组在血清肌酐、肌酐排泄率和肌酐清除率(主要结局)方面均无显著差异,表明8周肌酸补充对肾功能是安全的。

要点

  • 8周肌酸补充未显著改变外周动脉疾病患者的肌酐清除率。
  • 血清肌酐和肌酐排泄率在肌酸组与安慰剂组间无显著差异。
  • 症状性外周动脉疾病患者短期肌酸补充未损害肾功能。

核心结论

  • 8周肌酸补充对症状性外周动脉疾病患者的肾功能是安全的,未造成肾功能损害。

主要发现

  • 血清肌酐组间比较无显著差异(肌酸组:前1.00±0.15 mL/dL vs 后1.07±0.16 mL/dL;安慰剂组:前1.30±0.53 mL/dL vs 后1.36±0.47 mL/dL,P=0.590)。
  • 肌酐排泄率组间比较无显著差异(肌酸组:前81.73±43.80 mg/dL vs 后102.92±59.57 mg/dL;安慰剂组:前74.37±38.90 mg/dL vs 后86.22±39.94 mg/dL,P=0.560)。
  • 肌酐清除率组间比较无显著差异(肌酸组:前108±59 mL/min/1.73 m2 vs 后117±52 mL/min/1.73 m2;安慰剂组:前88±49 mL/min/1.73 m2 vs 后82±47 mL/min/1.73 m2,P=0.366)。

临床怎么用

  • 对于症状性外周动脉疾病患者,短期(8周)肌酸补充方案(负荷期20g/天×1周,维持期5g/天×7周)无需过度担心肾功能恶化。

局限性

  • 仅评估8周短期效应,缺乏长期安全性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Case studies and reviews have shown that creatine supplementation can affect kidney function. The objective of this study is to verify the effects of 8 weeks of creatine supplementation on renal function (creatinine clearance: primary outcome) in patients with symptomatic peripheral arterial disease. METHODS: Twenty-nine patients, of both genders, were randomized (1:1) in a double-blind manner for administration of Placebo (PLA; n = 15) or creatine monohydrate (Cr; n = 14). The supplementation protocol consisted of 20 g/day for 1 week divided into 4 equal doses (loading phase), followed by single daily doses of 5 g in the subsequent 7 weeks (maintenance phase). Before and after the supplementation period, markers of renal function, serum creatinine, creatinine excretion rate, and creatinine clearance were evaluated. The Generalized Estimation Equation Model was used for comparison between groups. The level of significance was P < 0.05. RESULTS: No significant differences were found between groups before and after the intervention for serum creatinine (Cr: pre 1.00 ± 0.15 mL/dL vs. post 1.07 ± 0.16 mL/dL; PLA: pre 1.30 ± 0.53 mL/dL vs. post 1.36 ± 0.47 mL/dL, P = 0.590), creatinine excretion rate (Cr: pre 81.73 ± 43.80 mg/dL vs. post 102.92 ± 59.57 mg/dL; PLA: pre 74.37 ± 38.90 mg/dL vs. post 86.22 ± 39.94 mg/dL, P = 0.560), or creatinine clearance (Cr; pre 108 ± 59 mL/min/1.73 m2 vs. post 117 ± 52 mL/min/1.73 m2; PLA: pre 88 ± 49 mL/min/1.73 m2 vs. post 82 ± 47 mL/min/1.73 m2, P = 0.366). CONCLUSIONS: Eight weeks of creatine supplementation is safe and does not compromise the renal function of patients with peripheral arterial disease.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Domingues WJR, Ritti-Dias RM, Cucato GG, et al. Does Creatine Supplementation Affect Renal Function in Patients with Peripheral Artery Disease? A Randomized, Double Blind, Placebo-controlled, Clinical Trial. Ann Vasc Surg. 2019. PMID: 31563660. doi:10.1016/j.avsg.2019.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。